The ARRIGE initiative presented from the ComunicaBiotec blog

Article by Lluis Montoliu at the blog of the association ComunicaBiotec on the launching and objectives of ARRIGE.

The ARRIGE initiative is being presented from various newspapers, journals, web sites and associations. One of the recent articles about ARRIGE, about its launching in Paris and its objectives, has been written (in Spanish) by Lluis Montoliu for the blog of ComunicaBiotec, a Spanish Association of Communication in Biotechnology. In this article, Lluis Montoliu describes the scenario where ARRIGE was born, the precedent activities and the future ahead, trying to promote the responsible use of genome editing technologies.


ARRIGE coverage from Spain

Article about the ARRIGE kick-off meeting published by the Spanish newspaper DIARIO MEDICO

The Spanish newspaper DIARIO MEDICO, specialized in the field of health and regularly read by many professional colleagues including those from Hospitals, Clinics and Biomedical research centres in Spain, covered the launching of the ARRIGE and our kick-off meeting in a recent article, written by José A. Plaza and published on April 8, 2018. The article is in Spanish and is entitled: “Toward an international governance in CRISPR“.

ARRIGE in Spanish: interview to Francisco J. M. Mojica on the origins of CRISPR

In this short video interview (in Spanish), as a brief summary of a much longer text in El País newspaper, the journalist visits Francisco J. M. Mojica (University of Alicante, Spain) who shows the saltworks of Santa Pola, near Alicante, where he first described the CRISPR arrays from an archaea, 25 years ago. Francis Mojica coined the name of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) at the end of 2001 and, two years later discovered that CRISPR were part of an adaptive immune system developed by prokaryotes (bacteria and archaea) as a defense mechanism against the virus (bacteriophages) and other molecules of genetic material that infected  or visited them. Ten years later, the CRISPR bacterial immune system was transformed into an efficient genome editing tool.